Danielle Croucher

485 total citations
15 papers, 100 citations indexed

About

Danielle Croucher is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Danielle Croucher has authored 15 papers receiving a total of 100 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Danielle Croucher's work include Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Danielle Croucher is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Danielle Croucher collaborates with scholars based in Canada, United States and Australia. Danielle Croucher's co-authors include Suzanne Trudel, Patrick T. Gunning, Zhihua Li, Sina Haftchenary, Trevor J. Pugh, Brent D. G. Page, Mark D. Minden, Michaël Sébag, Sangeeta Mehta and P. Leif Bergsagel and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Danielle Croucher

13 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danielle Croucher Canada 6 49 45 26 19 12 15 100
Ramona Crescenzo United States 4 52 1.1× 80 1.8× 16 0.6× 21 1.1× 5 0.4× 5 116
Bonnie Le United States 3 35 0.7× 124 2.8× 40 1.5× 16 0.8× 7 0.6× 4 157
Jorge Vaz Pinto Neto Brazil 4 50 1.0× 107 2.4× 39 1.5× 29 1.5× 6 0.5× 6 182
James Hayden United Kingdom 6 55 1.1× 71 1.6× 7 0.3× 22 1.2× 17 1.4× 13 154
Wendy Crist United States 8 79 1.6× 83 1.8× 73 2.8× 8 0.4× 7 0.6× 11 142
Katarzyna Anna Baranowska Norway 6 39 0.8× 120 2.7× 75 2.9× 7 0.4× 19 1.6× 11 176
Errin Samuëlsz United States 6 65 1.3× 70 1.6× 21 0.8× 20 1.1× 5 0.4× 13 123
Hiba Ahmad Zahreddine Canada 6 52 1.1× 214 4.8× 20 0.8× 20 1.1× 6 0.5× 9 243
Haixiang Cao China 4 104 2.1× 193 4.3× 19 0.7× 26 1.4× 8 0.7× 5 236
Bianca J. Lee United States 4 53 1.1× 60 1.3× 8 0.3× 10 0.5× 4 0.3× 9 99

Countries citing papers authored by Danielle Croucher

Since Specialization
Citations

This map shows the geographic impact of Danielle Croucher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Croucher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Croucher more than expected).

Fields of papers citing papers by Danielle Croucher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Croucher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Croucher. The network helps show where Danielle Croucher may publish in the future.

Co-authorship network of co-authors of Danielle Croucher

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Croucher. A scholar is included among the top collaborators of Danielle Croucher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Croucher. Danielle Croucher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ding, Chien‐Kuang Cornelia, Kevin Shee, Janet E. Cowan, et al.. (2025). External validation of a pathology-based multimodal artificial intelligence biomarker for predicting prostate cancer outcomes after prostatectomy.. Journal of Clinical Oncology. 43(16_suppl). 5106–5106.
2.
Markowski, Mark C., Yi Ren, Trevor J. Royce, et al.. (2024). Digital Pathology–based Artificial Intelligence Biomarker Validation in Metastatic Prostate Cancer. European Urology Oncology. 8(3). 755–762. 2 indexed citations
4.
Croucher, Danielle, Anup J. Devasia, Zhihua Li, et al.. (2023). Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression. Molecular Case Studies. 9(2). a006249–a006249. 5 indexed citations
5.
Eagles, Jenna, Arnavaz Danesh, Danielle Croucher, et al.. (2023). Cell-Free DNA from Blood or Bone Marrow as Alternatives to Bone Marrow Cells for Molecular Diagnostics and Monitoring of Multiple Myeloma. Blood. 142(Supplement 1). 4693–4693. 1 indexed citations
6.
Croucher, Danielle, Laura M. Richards, Daniel D. Waller, et al.. (2021). Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression. Nature Communications. 12(1). 6322–6322. 20 indexed citations
7.
Díaz-Mejía, J. Javier, Ping Luo, Samarth Patel, et al.. (2020). CReSCENT: CanceR Single Cell ExpressioN Toolkit. Nucleic Acids Research. 48(W1). W372–W379. 10 indexed citations
8.
Croucher, Danielle, Marta Chesi, Zhihua Li, et al.. (2018). A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma. Blood. 132(Supplement 1). 56–56. 3 indexed citations
9.
Chen, Christine I., Lisa W. Le, Ellen Wei, et al.. (2018). A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL). Leukemia & lymphoma. 60(4). 980–989. 7 indexed citations
10.
Pincus, Daniel, et al.. (2017). The utility and safety of flexible bronchoscopy in critically ill acute leukemia patients: a retrospective cohort study. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 65(3). 272–279. 5 indexed citations
11.
Croucher, Danielle, Christian Sandrock, Narmin Ibrahimova, et al.. (2016). Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care Unit. Canadian Respiratory Journal. 2016. 1–7. 13 indexed citations
12.
Li, Zhihua, Sina Haftchenary, Danielle Croucher, Patrick T. Gunning, & Suzanne Trudel. (2013). Abstract C246: SH-4-54, a novel small-molecule inhibitor of STAT3, demonstrates significant anti-tumor activity against multiple myeloma.. Molecular Cancer Therapeutics. 12(11_Supplement). C246–C246. 2 indexed citations
13.
Page, Brent D. G., Danielle Croucher, Zhihua Li, et al.. (2013). Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma. Journal of Medicinal Chemistry. 56(18). 7190–7200. 30 indexed citations
14.
Croucher, Danielle, Víctor H. Jiménez‐Zepeda, Brent D. G. Page, et al.. (2011). Abstract A201: The potent STAT3/5 inhibitor, BP-1–102, demonstrates significant antitumor activity against Waldenstrom macroglobulinemia.. Molecular Cancer Therapeutics. 10(11_Supplement). A201–A201. 1 indexed citations
15.
Croucher, Danielle, Zhihua Li, Ellen Wei, et al.. (2011). The Potent STAT3/5 Inhibitor, BP-1-102 Demonstrates Significant Anti-Tumor Activity Against Waldenstrom Macroglobulinemia. Blood. 118(21). 5101–5101. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026